subdomain VIII of the catalytic domain (1) (2) (3) (4) . This phosCadmium (Cd), a human carcinogen, can induce apoptosis phorylation is mediated by a protein kinase cascade that in various cell types. Three major mitogen-activated protein consists of a MAPK kinase kinase that phosphorylates and kinases (MAPKs), c-JUN N-terminal kinase (JNK), p38 activates one or more MAPK kinases (MKK) that, in turn, and extracellular signal-regulated kinase (ERK), have been phosphorylate and activate each MAPK (1) (2) (3) (4) . JNK is known shown to regulate apoptosis. In this study we explore the to be activated by MKK4 and MKK7 (4) . Similarly, p38 is ability of Cd to activate JNK, p38 and ERK, including their activated by MKK3, MKK6 and MKK4, whereas ERK is effects on Cd-mediated growth inhibition and apoptosis in activated by MKK1 and MKK2 (4) . Once activated, MAPKs a human non-small cell lung carcinoma cell line, CL3. The regulate gene expression through phosphorylation of downkinase activity of JNK was induced dose-dependently by stream transcriptional factors. For example, JNKs were 30-160 µM CdCl 2 . High cytotoxic doses of Cd (130- 160 originally identified by their ability to phosphorylate and µM) markedly activated p38, but low Cd doses did not.
activate the c-JUN N-terminal transactivation domain (5), Conversely, the activities of ERK1 and ERK2 were whereas, ERK phosphorylates an inhibitory C-terminal DNAdecreased by low cytotoxic doses of Cd (≤80 µM) and binding domain of c-JUN (6, 7) .
moderately activated by high Cd doses. Low cytotoxic
In general, the ERK cascade is activated by growth factors doses of Cd transiently activated JNK and simultaneously and is critical for cell proliferation (8) . Conversely, the JNK reduced ERK activity, whereas high cytotoxic doses of Cd and p38 pathways are stimulated by genotoxic agents and persistently activated JNK and p38. PD98059, an inhibitor cytokines mediating the stress response, growth arrest and of ERK upstream activators MAPK kinase (MKK) 1 and apoptosis (9) (10) (11) (12) (13) (14) . However, controversial evidence has indi-MKK2, greatly enhanced cytotoxicity and apoptosis in cells cated that more complex roles of these MAPK pathways exist treated with low Cd doses. In contrast, SB202190, an to transmit other ultimately distinct cellular effects in different inhibitor of p38, decreased the cytotoxicity and apoptosis cell lineages. For example, ERK promotes differentiation in induced by high Cd doses. Transient expression of a neuronal cells, T cells and muscle cells (15, 16) , in contrast to dominant negative form of JNK1, but not that of JNK2, transmiting mitogenic signals in fibroblasts. On the other hand, significantly increased the viability and prevented apoptosis stress-activated JNK and p38 have been associated with of Cd-treated cells. However, expression of wild-type JNK1 cell survival (17,18), anti-cytotoxicity (19,20), anti-apoptosis did not affect viability and apoptosis of Cd-treated cells.
(21,22), transformation (23-25), proliferation (26) and invasion Transfection of wild-type JNK2 or p38 enhanced apoptosis (27) . The complexities of the physiological roles of MAPKs of cells exposed to low Cd doses but did not affect those may be due partially to the duration of MAPK activities exposed to high Cd doses. The JNK activity stimulated by differentially regulating genes in various cell types. While low Cd doses was partially suppressed by expression of a transient ERK activation leads to proliferation, persistent dominant negative form of MKK7, but not a dominant activation mediates growth arrest or differentiation signals negative form of MKK4, indicating that MKK7 is involved (28) (29) (30) . In contrast, transient JNK and p38 induction could in JNK activation by Cd. Together, the results of this study provide a survival signal, whereas persistent activation induces suggest that JNK and p38 cooperatively participate in apoptosis (31, 32) . apoptosis induced by Cd and that the decreased ERK Cd is a ubiquitous environmental toxicant that has been signal induced by low Cd doses contributes to growth evaluated as a human carcinogen (33). The main sources of inhibition or apoptosis.
human exposure to Cd are tobacco smoke, food and industrial pollution. Cd is absorbed by inhalation and ingestion and has a biological half-life Ͼ25 years. For cigarette smoke, up to Introduction 60% of Cd deposited in the lung is absorbed (34) . In experiThree major mammalian mitogen-activated protein kinases mental animals Cd compounds have been shown to induce (MAPKs), extracellular signal-regulated kinase (ERK), c-JUN tumors in lung, testes, prostate, the hematopoietic system and N-terminal kinase (JNK) and p38 kinase, are regulated by at injection sites (33, 35 been shown to induce mRNA levels of several genes such as 24 h. The cells were treated with 500 µg/ml 3-(4,5-dimethyl-thiazol-2-yl) c-jun (44), c-myc (44), c-fos (45) , metallothionein genes (46) 2,5-diphenyl tetrazolium bromide (MTT) (Sigma Chemical Co., St Louis, and heme oxygenase (47, 48 
Amersham, Pharmacia Biotech). The reaction was performed at room temper-(100 U/ml), streptomycin (100 µg/ml) and fetal calf serum (10%). Cells were ature for 30 min and terminated by washing with HEPES binding buffer. maintained at 37°C in a humidified incubator containing 5% CO 2 in air.
Phosphorylated proteins were eluted with 30 µl of 1.5ϫ Laemmli sample Transfection buffer, boiled for 5 min and resolved on 10% SDS-polyacrylamide gels. The relative radioactivity was quantitated using a computing densitometer equipped Plasmids containing dominant negative forms of JNK1 (pCMV-JNK1-APF;
with the ImagQuant analysis program (Molecular Dynamics, Sunnyvale, CA). JNK1DN) or JNK2 (pSR-JNK2-APF; JNK2DN), MKK4 (JNKK[K116R];
The in-gel kinase assay was conducted by resolving 50 µg of total proteins MKK4KR) or wild-type forms of JNK1 and JNK2 were kindly provided by on a 10% SDS-polyacrylamide gel containing 40 µg/ml GST-cJun(1-79) Dr M. Karin (University of California, San Diego, CA) (5, 55, 56) . Plasmids fusion protein as described by Hibi et al. (5) . containing a dominant negative form of MKK7 (MKK7A) and the wild-type form of p38 were gifts from Dr J. Han (The Scripps Research Institute, La
Western blot analysis Jolla, CA) (57, 58) . Cells (4ϫ10 5 ) were plated in a 60 mm dish 1 day before Cellular protein (20-50 µg) was loaded onto 10% SDS-polyacrylamide transfection. Plasmids (5 µg) were transfected into CL3 cells by calcium gels. The protein bands were then transferred electrophoretically to PVDF phosphate co-precipitation. After incubation for 6 h, the cells were washed membranes (Micron Separations Inc., Westborough, MA). Membranes were with phosphate-buffered saline (PBS) and cultured in complete medium for probed with primary antibody, followed by a horseradish peroxidase-conjug-24 h, followed by maintenance in serum-free medium for 16-18 h. The cells ated second antibody (Bio-Rad, Hercules, CA). Phospho-specific antibodies were then subjected to Cd treatment.
for p38 (9211) and ERK (9101) were purchased from New England BioLabs Treatment Inc. (Beverly, MA). Anti-JNK1 antibody (G151-666) was purchased from Pharmingen (San Diego, CA). Anti-ERK2 (C-14) and anti-p38 (C-20) antibodCells in exponential growth were plated at a density of 1ϫ10 6 cells/100 mm ies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). dish and cultured in serum-free medium for 16-18 h before Cd treatment.
Antibody reactions were detected using the enhanced chemiluminescence Cadmium chloride (Merck, Darmstadt, Germany) was dissolved in MilliQ detection procedure according to the manufacturer's recommendations (Amerpurified water (Millipore, Bedford, MA). Cells were treated with CdCl 2 for sham, Pharmacia Biotech). 0.5-12 h in serum-free medium. In experiments to determine the effects of PD98059 (Calbiochem, San Diego, CA) and SB202190 (Calbiochem) on Isolation and analysis of RNA Cd-induced MAPKs, cell growth inhibition, cytotoxicity and apoptosis, cells Total RNA (15 µg), isolated by a guanidium isothiocyanate/phenol/chloroform were treated with these kinase inhibitors for 1 h and then co-exposed to CdCl 2 extraction procedure (60), was subjected to electrophoresis in a 1% agarosefor 3 h. At the end of treatment, the drug-containing medium was removed 2.2 M formaldehyde gel, transferred to nylon membranes and hybridized to and the cells were washed twice with PBS.
32 P-labeled DNA probes prepared by rediprime random primer labeling Cell growth (Amersham Pharmacia Biotech) with a specific activity of Ͼ1.5ϫ10 8 c.p.m.. Hybridization was performed overnight at 42°C in a solution containing 50% After treatment, the cells were cultured in medium containing 10% serum for formamide, 6ϫ SSC (1ϫ SSC ϭ 180 mM NaCl, 10 mM sodium citrate, pH 0-3 days before trypsinization. A portion of cells were mixed with 0.4% 8.0), 5ϫ Denhardt's reagent, 0.5% SDS and 100 µg/ml salmon sperm DNA. trypan blue (Gibco Life Technologies) for 15 min and the number of unstained Membranes were washed to a stringency of 0.1ϫ SSC, 0.1% SDS for 10 min cells were determined using a hemocytometer.
at 65°C and exposed to X-ray films.
Viability assay
Electrophoretic mobility shift assay Cells were seeded in 96-well plates at a density of 5ϫ10 3 cells/well and cultured in serum-free medium for 16-18 h before CdCl 2 treatment. The cells Nuclear protein was extracted as described by Andrews and Faller (61) . Binding reactions were performed at room temperature with 20 µl of a mixture were treated with CdCl 2 for 3 h in the presence or absence of kinase inhibitors. After treatment, the cells were cultured in medium containing 10% serum for containing 6 µg nuclear protein, 10 mM Tris-HCl, pH 7.6, 3% glycerol, 50 mM KCl, 2.25 mM MgCl 2 , 0.125% NP-40, 2 µg bovine serum albumin and 1 µg poly(dI·dC). After incubation for 20 min, 1 ng 32 P-labeled oligonucleotides (~20 000 c.p.m.) was added and incubated at room temperature for another 30 min. The DNA-protein complexes were resolved on 6% non-denaturing polyacrylamide gels at 4°C, dried and visualized by autoradiography. For competition experiments, a 100-fold excess of unlabeled oligonucleotides was added to the reaction mixture before adding the labeled probe. The sequences of the oligonucleotides used, specific for the AP-1 binding site and that containing a point mutation, were 5Ј-CGATCGCAT-GACTCACTCAAT-3Ј and 5Ј-CGATCGCAgGACTCACTCAAT-3Ј, respectively (the AP-1 binding site is underlined and the point mutation is in lower case; only one strand is shown).
Results

Growth rate and viability of Cd-treated CL3 cells
The effects of Cd on the cellular growth rate and viability of human lung adenocarcinoma CL3 cells were examined in order to understand Cd cytotoxicity. Cells in exponential growth were cultured in serum-free medium for 18 h before they were exposed to various CdCl 2 concentrations for 3 h. The cells were maintained in culture in complete medium for 0-3 days and the numbers of viable cells were determined by the trypan blue exclusion assay. Figure 1A shows that the growth rates of CL3 cells treated with 30 or 60 µM Cd were not significantly different from untreated cells, whereas 130 or 160 µM Cd markedly inhibited cell growth (P Ͻ 0.01).
Although the number of viable cells was decreased by 80 µM Cd (P Ͻ 0.05), these cells could proliferate at a normal rate 2-3 days after treatment ( Figure 1A ). The relative survival of cells treated with Cd was determined by the MTT assay. Approximately 70 and 5% of cells survived after exposure to 80 and 160 µM Cd, respectively ( Figure 1B) . shift assay. The nuclear extract obtained from untreated control cells had little AP-1 DNA-binding activity, whereas it was markedly induced by 100-200 µM Cd in CL3 cells ( Figure  2B ). Competition experiments showed that the induced AP-1 rylation sites of the catalytic domain. CL3 cells in exponential transcription factor interacts with a specific DNA AP-1-binding growth were serum starved for 18 h prior to CdCl 2 treatment sequence but does not interact with an AP-1 site containing a for 3 h. Western blot analyses showed that the amounts of point mutation ( Figure 2B ). These results clearly show that JNK, p38 and ERK proteins in Cd-treated cells were the same Cd in the absence of serum can induce c-jun mRNA levels as in untreated cells (Figure 3 ), whereas activation of these and AP-1 DNA-binding activity in CL3 cells.
Induction of c-jun expression and AP-1 DNA-binding ability by Cd in CL3 cells
MAPKs was markedly altered by Cd in a dose-dependent manner ( Figure 3 ). JNK activity was increased 2-fold by Cd alters the activities of JNK, p38 and ERK in CL3 cells 30 µM Cd and dramatically increased by 60-160 µM Cd The transcription of c-jun is regulated by binding of a c-JUN/ ( Figure 3A) . Cd concentrations of 130-160 µM markedly ATF-2 heterodimer to the promoter (2). Both c-JUN and ATFactivated p38 but lower Cd concentrations (15-80 µM) did 2 are activated by the JNK pathway; ATF-2 is also activated not increase it ( Figure 3B ). In contrast, ERK activity was by the p38 pathway (2, 4) . Moreover, AP-1 activation is decreased by 15-80 µM Cd and increased 4-fold at higher Cd correlated with the ERK pathway (2). We therefore examined concentrations (130-160 µM) ( Figure 3C ). In-gel kinase assays the ability of Cd to induce JNK, p38 and ERK activities in showed that both JNK1 and JNK2 activities were induced in serum-starved CL3 cells. JNK activity in CL3 cells was cells exposed to 100 µM Cd for 3 h ( Figure 3D ). The induced determined using [γ-32 P]ATP and a specific JNK substrate, kinase activities were higher than that induced by 40 J/m 2 GST-cJUN (1-79) . Activation of p38 and ERK were determined using specific antibodies recognizing the dual phospho-UVC, a well-known JNK activator (5; Figure 3D ). and increased above the control levels by 6-12 h treatment (Figure 4) .
To further investigate the stability of Cd-activated JNK and p38, Cd-treated CL3 cells were washed with PBS, cultured in Cd-free medium for another 0, 1 or 8 h and then assayed for JNK and p38 activities. Figure 5 shows that the JNK activity induced by 80 µM Cd markedly decreased with increased incubation time post-treatment, whereas JNK activity induced by 150 µM Cd remained at high levels when the metal was removed from the medium for 8 h ( Figure 5) . The results increase it ( Figure 5) . 7A). In contrast, 50 µM PD98059 co-administration enhanced apoptotic cell induction by 80 µM Cd (P Ͻ 0.05; Figure 7A ). Additionally, co-administrating PD98059 or SB202190 with
Opposing roles of ERK and p38 in Cd-induced cytotoxicity
Cd did not affect the JNK activity induced by Cd ( Figure 7B ). and apoptosis PD98059 or SB202190 alone neither increased the number of To inspect the roles of ERK and p38 signaling pathways in apoptotic cells nor JNK activity above untreated control cells. Cd cytotoxicity, CL3 cells were exposed to Cd in the presence
The results suggest that the p38 signal pathway, persistently of the kinase inhibitors PD98059 and SB202190, specific for activated by high doses of Cd, participates in cytotoxicity and MKK1/2 (ERK upstream kinases) and p38, respectively. The apoptosis. Also, decreased ERK signaling by low doses of Cd numbers of viable cells were determined using the trypan blue contributes to growth arrest or apoptosis. exclusion assay. Figure 6A shows that PD98059 (50 µM)
Roles of JNK1 and JNK2 in cell growth and apoptosis of decreased the viability of cells exposed to 80 µM Cd (P Ͻ Cd-treated CL3 cells 0.01, day 3), whereas SB202190 (10 µM) potentiated the numbers of viable cells in populations treated with 130 µM Recent evidence indicates that individual JNK isoforms may transmit distinct signals to regulate protective and cell deathCd (P Ͻ 0.01, days 2 and 3). The effects of these kinase inhibitors on Cd-induced cytotoxicity were also determined by inducing pathways. For example, expression of JNK1 but not JNK2 restores the ability of yeast lacking HOG1 (a p38 MTT assay. The results confirmed that PD98059 greatly enhanced Cd cytotoxicity (P Ͻ 0.01, 80 and 120 µM), while homolog) to grow in hypertonic medium (62). Expression of dominant negative JNK1 (JNK1DN) but not dominant negative SB202190 inhibited the cytotoxicity induced by high doses of Cd (P Ͻ 0.01, 160 µM; Figure 6B ). These results indicate that JNK2 (JNK2DN) markedly increased the resistance of small cell lung cancer cells to UV-induced apoptosis (63) . Therefore, ERK and p38 have opposing roles in Cd-mediated cytotoxicity.
The annexin V-FITC binding assay was adopted to deterwe investigated the effect of Cd-induced JNK1 and JNK2 on cell growth and apoptosis by transfection of CL3 cells with mine the role of apoptosis in Cd-mediated cell death. Figure  7A shows that Cd induced significant numbers of apoptotic vectors containing JNK1DN, JNK2DN or the wild-type forms of JNK1 and JNK2. Cells transfected with 5 µg of vectors cells in a dose-dependent manner,~40% of cells undergoing apoptosis 8 h post-exposure to 130 µM Cd for 3 h. Cowere allowed 2 days for expression and then treated with Cd performed as described in Figure 8 . Cells undergoing apoptosis were The numbers of viable cells were determined 24 h after Cd treatment by the examined 24 and 8 h post-exposure to 80 and 120 µM Cd, respectively, trypan blue exclusion assay. Data were obtained from three or four using the annexin V-FITC binding assay. Results were obtained from independent experiments and bars represent SEMs. The statistical analysis between four or six experiments and bars represent SEMs. The statistical compares cells containing JNK1DN treated with Cd and those containing analyses compare cells containing JNK1DN, JNK2 or p38 treated with Cd pcDNA3 exposed to the same dose of Cd using Student's t-test (*P Ͻ 0.05 and those containing pcDNA3 exposed to the same dose of Cd using and **P Ͻ 0.01).
Student's t-test (*P Ͻ 0.05 and **P Ͻ 0.01).
for 3 h in serum-free medium. Figure 8A shows that transient expression of JNK1DN and JNK2DN blocked the activity of JNK induced by Cd. JNK1DN was more efficient than JNK2DN in arresting activation of JNK by Cd, suggesting that Cd activated JNK1 more than JNK2. Transient expression of JNK1DN or JNK2DN did not affect the activities of p38 and ERK induced by Cd (data not shown). The effects of Cdactivated JNK1 and JNK2 on cell growth inhibition and apoptosis were determined using the trypan blue exclusion 120 µM Cd, P Ͻ 0.01), whereas JNK2DN had no effect ( Figure 8B ). Similarly, JNK1DN significantly abated Cd-MKK7 but not MKK4 is involved in Cd induction of JNK activity induced apoptosis but JNK2DN did not (Figure 9 ). Conversely, transfection of wild-type JNK1 into CL3 cells influenced Both MKK4 and MKK7 are reported to be upstream activators neither growth inhibition nor apoptosis caused by Cd (Figures of JNKs by various stimuli (64-68). To determine the effect 8B and 9). In contrast, transfection of wild-type JNK2 or p38 of these MKKs on Cd-induced JNK activity, we transfected could enhance apoptosis induced by low Cd doses in CL3 CL3 cells with a dominant negative form of MKK4 (MKK4KR) cells (P Ͻ 0.05; Figure 9 ). These results suggest that JNK1 or MKK7 (MKK7A). The results showed that 35% of the in combination with JNK2 and p38 transmit a signal for Cd-JNK activity stimulated by Cd (80 µM) was suppressed by expression of MKK7A in CL3 cells (Figure 10 ). In contrast, induced growth inhibition and apoptosis. expression of MKK4KR enhanced Cd-induced JNK activity MKPs are encoded by immediate early genes and induced in response to environmental stresses and growth factor stimu-2-fold ( Figure 10 ). The ability of MKK7A to suppress Cdinduced JNK activity, however, was not observed in cells lation to selectively down-regulate MAPK activities (69) . For example, the cytosolic M3/M6 MKP is highly specific for treated with 130 µM Cd (data not shown).
JNK and p38 inactivation, while the association of MKP-3 with ERK in the cytosol markedly stimulates ERK dephosphoDiscussion rylation and inactivation (72-74). Activation of the JNK pathway in NIH 3T3 fibroblasts could result in MKP-1 gene In the present study we have examined the ability of CdCl 2 to activate JNK, p38 and ERK and the effects of these MAPKs expression and ERK inactivation, suggesting the existence of cross-talk between the JNK and ERK signaling pathways (75). on Cd-mediated growth arrest and apoptosis in CL3 human lung adenocarcinoma cells. Cd at low cytotoxic doses transiently However, Cd did not affect the total amounts of MKP-1 in CL3 cells (S.-M.Chuang, unpublished data), suggesting that activated JNK and concomitantly reduced ERK activity, whereas high cytotoxic doses of Cd persistently activated JNK MKP-1 may not be involved in the regulation of MAPK activities in Cd-treated cells. Whether Cd affects expression and p38. Co-administration of Cd with specific inhibitors to block ERK or p38 signaling showed that these pathways have of MKPs deserves further investigation.
Proteins that interact and suppress MAPKs may also block opposing effects on the growth arrest and apoptosis induced by Cd. Inhibition of ERK activity by PD98059 accelerated these signaling pathways. For example, GST π was recently identified as associated with JNK and suppressed its kinase growth inhibition and apoptosis induced by low Cd doses, suggesting that ERK is involved in cell proliferation and antiactivity (71) . The anti-apoptotic effect of thioredoxin is reported to be associated with inhibition of ASK1, a MAPK kinase apoptosis. Inhibition of p38 activity by SB202190, however, enhanced cell viability and prevented apoptosis induced by kinase that activates JNK and p38 (70) . Both GST and thioredoxin play important roles in detoxification of reactive high Cd doses, suggesting that persistently activated p38 participates in apoptosis. Transient expression of JNK1DN, oxygen species and the balance of cellular redox levels (76, 77) . The genotoxicity of Cd is correlated with intracellular reactive but not JNK2DN, in CL3 cells markedly increased cell viability and prevented apoptosis in Cd-treated populations. On the oxygen species (39, 78, 79) . Cd may down-regulate the functions of GST π and thioredoxin, thereby elevating JNK and p38 other hand, transfection of wild-type JNK2 or p38, but not JNK1, could enhance apoptosis induced by low Cd doses in activities. Moreover, the scaffold or adaptor proteins that interact with multiple components of a specific signal cascade CL3 cells. Low Cd doses did not activate p38 and may activate JNK1 more than JNK2. This would explain in part why can influence activation and function of distinct kinases. For example, the adaptor protein JIP-1 (JNK interacting protein transfection of wild-type p38 or JNK2 enhanced apoptosis when the cells were exposed to low Cd doses. The results 1), which specifically binds to JNK, is required for JNK activation (80) , however, JIP-1 overexpression causes cytoshown here suggest that Cd may sequentially activate JNK1, JNK2 and p38 in a dose-dependent manner to cooperatively plasmic retention of JNK and subsequently suppresses JNK activity to phosphorylate nuclear transcriptional factors (80, 81) . induce apoptosis. Decreased ERK activity may combine with increased JNK activity to transmit a signal temporally causing It will be important to explore the mechanism by which Cd activation of JNK and p38 is mediated by its capability to growth arrest by low Cd doses in CL3 cells.
Separate signaling modules may provide specific responses block cellular MAPK inhibitors. We have shown here that the expression of c-jun mRNA of MAPK pathways to different stimuli. For example, MKK1 and MKK2 specifically activate the ERK group, MKK3 and was markedly increased in CL3 cells treated with 50-150 µM Cd for 3 h. JNK was also activated by the same Cd doses. MKK6 specifically activate p38 and MKK4 activates both p38 and JNK (2) . Recently, MKK7/JNKK2 was identified as These findings agree with the notion that JNK phosphorylates c-JUN/ATF-2 which binds to the promoter of c-jun (2) . The phosphorylating and activating JNK, but not p38 or ERK (67, 68) . We have demonstrated that JNK activity stimulated Cd-induced c-jun mRNA would enhance c-JUN levels, thereby increasing AP-1 DNA-binding activity (2) . However, AP-1 by low Cd doses is suppressed by expression of a dominant negative form of MKK7. In contrast, expression of a dominant DNA-binding activity was induced at somewhat higher doses of Cd. The failure to observe enhanced AP-1 binding activity negative form of MKK4 moderately enhances Cd-induced JNK activity. It has been shown that JNK activation by various at the low Cd doses that were able to induce JNK kinase activity and c-jun expression may be due in part to the fact stimuli is mediated differentially through MKK4 and MKK7. For example, tumor necrosis factor α and interleukin 1 activate that the specific AP-1-binding site used here was the promoter sequence of gadd153. Furthermore, activated JNK is not MKK7 much more than MKK4, suggesting that JNK activation by these stimuli is primarily through MKK7; anisomycin and always correlated with increased levels of c-jun transcripts and AP-1 binding activity (82, 83) . UV activate MKK4 more than MKK7 (64,66). The results of this study suggest that JNK activation by Cd is at least in
The cytotoxicity of Cd is highly associated with the levels of intracellular metallothionein, which sequesters Cd and part by activation of its upstream activator MKK7 and is independent of MKK4 in CL3 cells. Nevertheless, kinasealleviates its toxicity (84 
